Overview

PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

Status:
Not yet recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
PD1-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer
Phase:
Phase 1
Details
Lead Sponsor:
Zhejiang University
Collaborator:
Bioray Laboratories